Gastroesophageal reflux disease and obesity: who is to blame and what to do?
Abstract
The article is about the results of our research of the comoibidity of GERD and obesity. Patients with GERD was performed daily pH-impedancemetry of upper gastrointestinal tract, fibrogastroscopy, anthropometric survey, impedancemetry of body. Body mass index and the percentage of body fat had no significant correlation with functional disturbances in the gastroesophageal area, in contrast to the waist circumference and against the waist circumference / hips circumference. With an increase in waist circumference and waist circumference / hips circumference noted a significant increase in the time of bolus in the esophagus due to the presence of weakly acidic and alkaline bolus, but not acidic.
About the Authors
V. I. Simanenkov
North-Western State Medical University n.a. I. I. Mechnikov
Russian Federation
Russian Federation
S. V. Tikhonov
North-Western State Medical University n.a. I. I. Mechnikov
Russian Federation
Russian Federation
N. B. Lishchuk
North-Western State Medical University n.a. I. I. Mechnikov
Russian Federation
Russian Federation
References
1. Jacobson B. S., Somers S. C., Fuchs C. S. et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006; 354 (22): 2340-8.
2. Nocon M., Labenz J., Jaspersen D. et al. Association of body mass index with heartburn, regurgitation, and esophagitis: results of the progression of gastroesophageal reflux disease study. J Gastroenterol Hepatol. 2007; 22 (11): 1728-1731.
3. El-Serag H.B., Ergun G. A., Pandolfino J. et al. Obesity increases esophageal acid exposure. Gut. 2007; 56 (6): 749-755.
4. Ruhl C.E., Everhart J.E. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: The NHANES I Epidemiologic follow up study. First National Health and Nutrition Examination Survey. Ann Epidemiol. 1999; 9:424-435.
5. Corley D. A., Kubo A., Levin T. R. et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007; 133 (1): 34-41.
6. Hampel H., Abracham N., El-Serag H. B. Meta-analisis: obesity and the risk of GERD and its complications. Ann Int Med. 2005; 143 (3): 199-211.
7. Mathus-Vliegen E.M., M. van Weeren, P. V. Van Eerten LOS function and obesity: the impact of untreated obesity, weight loss, and chronic gastric balloon distension. Digestion. 2003; 68: 161-168.
8. Fraser-Moodie C.A., Norton B., Gornall C., et al. Weight loss has an independent beneficial effect on symptoms of gastrooesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999; 4: 337-340.
9. O’Brien T.F. Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans. J Clin Gastroenterol. 1980; 2: 145-148.
10. Kendrick M. L., Houghton S. G. Gastroesophageal reflux disease in obese patients: the role of obesity in management. Dis Esophagus. 2006; 19 (2): 57-63.
11. Wildi S. M., Tutuian R., Castell D. O. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004; 99: 1645-1651.
12. Wilson L. J., Ma W., Hirschowtiz B. I. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol. 1999; 94: 2840-2844.
13. Wu J. C., Mui L. M., Cheung C.M. et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007; 132 (3): 883-889.
14. Pandolfino J. E., El-Serag H.B., Zhang Q. et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006; 130 (3): 639-649.
15. Chang P. Obesity and GERD. Gastroenterol Clin N Am. 2014; 43: 161-173
16. Wisen O., Johansson C. Gastrointestinal function in obesity: motility, secretion, and absorption following a liquid test meal. Meta. 1992; 41: 390-395.
17. Симаненков В. И., Тихонов С. В., Лищук Н. Б. Гетерогенность ГЭРБ. Миф или реальность. РМЖ. 2016; 17: 1119-1124
18. Sifrim D., Dupont L, Blondeau K. et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut. 2005; 54:449-54.
19. Sifrim D., Mittal R., Fass R. et al. Review article: Acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007; 5 (9): 1003-17.
20. Boeckxstaens G. E., Smout A. Systematic review: Role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophagealreflux disease. Aliment Pharmacol Ther. 2010; 32: 334-43.
21. Giurcan R., Voiosu T.A. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Rom J Intern Med. 2010; 48: 9-15.
22. Scarpellini E., Vos R., Blondeau K. et al. Functional dyspepsia: a pragmatic approach. Aliment Pharmacol Ther. 2011; 33 (1): 99-105.
23. Лищук Н. Б., Симаненков В. И., Тихонов С. В. Дифференцированная терапия «некислых» форм гастроэзофагеальной рефлюксной болезни. Терапевтический архив. 2017; 89 (4): 57-63.
24. www.rlsnet.ru/tn_index_id_36285.htm. Обращение от 21.09.2017.
25. https://www.rlsnet.ru/tn_index_id_3308.htm. Обращение от 21.09.2017.
Review
For citations:
Simanenkov V.I., Tikhonov S.V., Lishchuk N.B. Gastroesophageal reflux disease and obesity: who is to blame and what to do? Medical alphabet. 2017;3(27):5-10. (In Russ.)
Views:
334
Email this article 